PL84352B1 - - Google Patents
Download PDFInfo
- Publication number
- PL84352B1 PL84352B1 PL17596572A PL17596572A PL84352B1 PL 84352 B1 PL84352 B1 PL 84352B1 PL 17596572 A PL17596572 A PL 17596572A PL 17596572 A PL17596572 A PL 17596572A PL 84352 B1 PL84352 B1 PL 84352B1
- Authority
- PL
- Poland
- Prior art keywords
- hydrogen
- general formula
- edema
- formula
- halogen
- Prior art date
Links
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 235000011007 phosphoric acid Nutrition 0.000 claims description 5
- 125000003277 amino group Chemical group 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 230000002378 acidificating effect Effects 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 150000007522 mineralic acids Chemical class 0.000 claims description 3
- 150000007524 organic acids Chemical class 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical class C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims description 2
- 229910000510 noble metal Inorganic materials 0.000 claims description 2
- 239000002798 polar solvent Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 206010030113 Oedema Diseases 0.000 description 13
- 239000000126 substance Substances 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 241000700159 Rattus Species 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 239000005995 Aluminium silicate Substances 0.000 description 7
- 235000012211 aluminium silicate Nutrition 0.000 description 7
- 239000000679 carrageenan Substances 0.000 description 7
- 229940113118 carrageenan Drugs 0.000 description 7
- 235000010418 carrageenan Nutrition 0.000 description 7
- 229920001525 carrageenan Polymers 0.000 description 7
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 7
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 7
- 208000025865 Ulcer Diseases 0.000 description 6
- 229960002895 phenylbutazone Drugs 0.000 description 5
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 230000007059 acute toxicity Effects 0.000 description 4
- 231100000403 acute toxicity Toxicity 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 230000001562 ulcerogenic effect Effects 0.000 description 3
- -1 2'-fluoro-4-biphenylyl Chemical group 0.000 description 2
- 208000008469 Peptic Ulcer Diseases 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 230000002322 anti-exudative effect Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 231100001274 therapeutic index Toxicity 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- KFKVRZLUPOYKCL-UHFFFAOYSA-N 2-[4-(2-fluorophenyl)phenyl]oxolane Chemical compound FC1=C(C=CC=C1)C1=CC=C(C=C1)C1OCCC1 KFKVRZLUPOYKCL-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- RHLVAWHROJGHTG-UHFFFAOYSA-N 4-(4-phenylphenyl)butan-1-ol Chemical class C1=CC(CCCCO)=CC=C1C1=CC=CC=C1 RHLVAWHROJGHTG-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000906446 Theraps Species 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical compound [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 210000000548 hind-foot Anatomy 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- YLGXILFCIXHCMC-JHGZEJCSSA-N methyl cellulose Chemical compound COC1C(OC)C(OC)C(COC)O[C@H]1O[C@H]1C(OC)C(OC)C(OC)OC1COC YLGXILFCIXHCMC-JHGZEJCSSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 230000001175 peptic effect Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL17596572A PL84352B1 (cs) | 1972-10-13 | 1972-10-13 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL17596572A PL84352B1 (cs) | 1972-10-13 | 1972-10-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL84352B1 true PL84352B1 (cs) | 1976-03-31 |
Family
ID=19969818
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17596572A PL84352B1 (cs) | 1972-10-13 | 1972-10-13 |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL84352B1 (cs) |
-
1972
- 1972-10-13 PL PL17596572A patent/PL84352B1/pl unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI69451C (fi) | Foerfarande foer framstaellning av antiinflammatoriska 4,5-diaryl-2-nitroimidazoler | |
| DE2305339C3 (de) | Imidazo [4,5-b] pyridine, ihre Herstellung und ihre Verwendung als Cardiötonica | |
| FI72714B (fi) | Foerfarande foer framstaellning av farmakologiskt vaerdefulla 4-acylamino-fenyl-etanolaminer. | |
| CH521355A (de) | Verfahren zur Herstellung von aromatischen Äthern | |
| DE1518207B1 (de) | Verfahren zur Herstellung von neuen Phenylcyclopropanderivaten bzw. deren Salzen und quaternaeren Ammoniumverbindungen | |
| PL84342B1 (cs) | ||
| DE2449270C3 (de) | 2-[3-(4-Diphenylmethyl-piperarino)-propyl] -s-triazolo [13-a eckige Klammer zu pyridin, seine nicht toxischen Salze mit Säuren und ein Verfahren zu ihrer Herstellung | |
| IL35098A (en) | Pharmaceutical compositions containing mono-amides of phthalic and pyridine dicarboxylic acids | |
| CH670389A5 (cs) | ||
| PL84352B1 (cs) | ||
| US4315862A (en) | Process for preparing cannabichromene | |
| DE2429290A1 (de) | Tricyclische kondensierte imidazolderivate und verfahren zu ihrer herstellung | |
| DE2128375C3 (de) | Basische substituierte Alkylidenamino-oxyalkyl-carbonsäureester, deren Säureadditionssalze, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate | |
| DE2856908A1 (de) | Neue chinoloncarbonsaeure-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische praeparate | |
| DE1960910B2 (de) | Benzylidenamino-oxyalkancarbonsäuren und deren Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate | |
| PL84343B1 (cs) | ||
| PL92388B1 (cs) | ||
| EP0026321B1 (de) | 6-Imidazol-1-yl-3-hydrazino-pyridazine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| PL84353B1 (cs) | ||
| EP0423524A2 (en) | Propiophenone derivatives and their preparation and pharmaceutical use | |
| DE4411660A1 (de) | Verwendung von Xanthinderivaten zur Reduktion der pathologischen Hyperreagibilität eosinophiler Granulozyten, neue Xanthinverbindungen und Verfahren zu deren Herstellung | |
| DE2630015A1 (de) | Neue polymethylen-4,5-pyrazole, verfahren zu ihrer herstellung und ihre therapeutische anwendung | |
| AT314530B (de) | Verfahren zur Herstellung von neuen 5- bzw. 4-Nitroimidazolderivaten und ihren Salzen | |
| SU1099564A1 (ru) | Соли 4-(3,3-диметилтриазено-N-ацетилбензолсульфамида, про вл ющие противовоспалительную активность | |
| CA1154772A (en) | Substituted 2-(pyridyl-cyclopropyl)-chromones and process for their preparation |